Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€97.42

€97.42

2.790%
2.64
2.790%
-

-

 
18:02 / Tradegate WKN: A14SDD / Name: Blueprint / Stock / Biotechnology & Medical Research / Mid Cap /
Latest predictions
04.05.24
-1.10%
buy
12.04.24
14.61%
buy
Best running prediction
-
12.04.24
14.61%
buy
Your prediction

Blueprint Medicines Corp Stock

Blueprint Medicines Corp gained 2.790% today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Blueprint Medicines Corp stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Blueprint Medicines Corp in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Blueprint Medicines Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Blueprint Medicines Corp 2.790% -3.384% 9.903% 73.908% 14.885% 22.740% -
Ironwood Pharmaceuticals -7.500% 0.840% -22.581% -40.594% -41.176% -40.594% -
Novocure Ltd 5.330% 1.176% 83.311% -72.334% 44.658% -86.108% -
Iovance Biotherapeutics Inc. -1.260% -0.917% -14.206% 12.898% 21.747% -35.857% -